tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mason Carrico, 65 are a BUY (85.53%), 11 are a HOLD (14.47%).
Analyst Mason Carrico, currently employed at STEPHENS, carries an average stock price target met ratio of 68.86% that have a potential upside of 34.61% achieved within 282 days.
Mason Carrico’s has documented 125 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NTRA, Natera at 12-Aug-2026.
Analyst best performing recommendations are on CTKB (CYTEK BIOSCIENCES).
The best stock recommendation documented was for CTKB (CYTEK BIOSCIENCES) at 12/13/2023. The price target of $9 was fulfilled within 2 days with a profit of $0.98 (12.22%) receiving and performance score of 61.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Aug-2019
$44
$11.67 (36.10%)
$50
1 months 11 days ago
(03-Aug-2026)
6/8 (75%)
$13.61 (44.78%)
192
Buy Since 03-Sep-2021
$40
$15.7 (64.61%)
$50
4 months 25 days ago
(20-Apr-2026)
8/12 (66.67%)
$14.84 (58.98%)
373
Buy Since 19-Aug-2019
$44
$11.67 (36.10%)
$41
6 months 18 days ago
(27-Feb-2026)
16/22 (72.73%)
$14.43 (48.80%)
358
Buy Since 14-Dec-2023
$47
$22.7 (93.42%)
$43
7 months 19 days ago
(26-Jan-2026)
2/3 (66.67%)
$3.96 (9.20%)
43
Buy Since 30-Apr-2021
$52
$27.7 (113.99%)
$35
8 months 2 days ago
(12-Jan-2026)
5/8 (62.5%)
$12.34 (31.11%)
348
Which stock is Mason Carrico most bullish on?
Which stock is Mason Carrico most reserved on?
What Year was the first public recommendation made by Mason Carrico?
